210P Anti-CTLA-4 overcomes inhibitory effect of PD1high regulatory T cell on circulating antitumor CD4+ Th1 response in patients treated by anti-PD(L)-1. (December 2022) - Marguier, A.; Perreira, V.; Wespiser, M.; Lecoester, B.; Boullerot, L.; Malfroy, M.; Nardin, C.; Laheurte, C.; Orillard, E.; Adotevi, O.